Back to Search
Start Over
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
- Source :
-
Nature medicine [Nat Med] 2017 Jun 06; Vol. 23 (6), pp. 788. - Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 1546-170X
- Volume :
- 23
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Nature medicine
- Publication Type :
- Academic Journal
- Accession number :
- 28586337
- Full Text :
- https://doi.org/10.1038/nm0617-788a